Home
Search
Search Results
Previously Searched
3124 results found
Expand All
Apply All
3124 results found

Good Day BIO: The war on drug-resistant TB
Good Day BIO Newsletter  •  August 25, 2022
Today, we look at the rise of deadly, drug-resistant TB—and how policy could help address it—plus, why biotech is an important part of the World Water Week conversation. (588 words, 2 minutes, 56 seconds)
Read More

Good Day BIO: Regulatory uncertainty hurts efforts to feed the world
Good Day BIO Newsletter  •  August 23, 2022
Biotech can help feed the world—but regulatory uncertainty is thwarting the effort, says BIO’s Dr. Michelle McMurry-Heath. Plus, late-stage cervical cancer sees an unnecessary upward trend. (738 words, 3 minutes, 41 seconds)  P.S. BIO’s Michele Oshman interviews Rep. Buddy Carter (R-GA) about how federal policies affect patients during Georgia Bio’s Patient Advocacy Summit today—get the details and register.
Read More

Good Day BIO: Inflation Reduction Act and ag biotech
Good Day BIO Newsletter  •  August 23, 2022
We’ve talked a lot about how the Inflation Reduction Act will harm drug R&D—and that’s still true—but today, we look at the good news for ag biotech and climate solutions. Plus, a recent HHS investigation looks at how private Medicare insurers and middlemen steer patients away from cheaper generics. (798 words, 3 minutes, 59 seconds)
Read More

Good Day BIO: Drought technology and vaccine access
Good Day BIO Newsletter  •  August 22, 2022
Another slow week in Washington, D.C. ahead—but the heat’s on America’s farmers struggling with drought. Meanwhile, we’ve talked a lot about how the Inflation Reduction Act will harm drug R&D—and that’s still true—but today, we look at the silver linings for access to vaccines. (606 words, 3 minutes, 1 second)
Read More

Good Day BIO: White House accelerates monkeypox vaccines, treatments
Good Day BIO Newsletter  •  August 19, 2022
Another slow summer Friday in D.C.—but we have the details on what the White House is doing to accelerate access to monkeypox vaccines and treatments, as well as new research on how gene editing led to greater soybean yield. (601 words, 3 minutes)
Read More

Good Day BIO: Time's running out for SBIR/STTR
Good Day BIO Newsletter  •  August 18, 2022
Two federal programs that have been driving small business innovation for 40 years are in danger of running out of money—we take a deep dive. Plus, bluebird bio’s big approval and what we need to do about the bees. (732 words, 3 minutes, 39 seconds)
Read More

Good Day BIO: New polio case was preventable with vaccination
Good Day BIO Newsletter  •  August 17, 2022
Just when you think you can take a summer break, you learn that polio is circulating in the U.S. Here’s what we know—and how vaccination can prevent it. Plus, COVID-19 caused many to forget about Zika—but it’s reemerging as a risk. (635 words, 3 minutes, 10 seconds)
Read More

Good Day BIO: Bioplastics business is booming
Good Day BIO Newsletter  •  August 16, 2022
The bioplastics business is booming, with companies investing billions into biotech-derived plastic alternatives—we tell you about a few. Plus, August is Psoriasis Action Month, and the National Psoriasis Action Foundation has resources about the links to stress and mental health. (586 words, 2 minutes, 55 seconds)
Read More

With Plans to Build World-Class Event in 2023, BIO Cancels 2022 Impact Ag & Environment Conference
Agriculture & Environment, BIO One-on-One Partnering  •  Press Release  •  August 15, 2022
The Impact Ag & Environment Conference hosted by the Biotechnology Innovation Organization has been canceled for 2022. BIO is shifting its focus to planning a must-attend conference in Raleigh, N.C., in September 2023.BIO had planned to host the first in-person BIO Impact Ag & Environment Conference since 2019 this September 19-21 in Omaha, Neb. Before that, the conference was known as the BIO World Congress.“As BIO evaluates how best to serve our members and advance the interests of the agriculture and environment biotech sector, we have decided not to hold this year’s BIO Impact Conference,” said BIO’s President & CEO Dr. Michelle McMurry-Heath. “This cancellation shows how committed we are at BIO to ensuring we safely host an event that is successful and reflects the priority we place on agricultural technology and environmental sustainability issues. We’re not going to rush this; we’re going to do it right.”“While we deeply regret having to postpone our plans for a post-COVID reunion of leaders who are eager to get together and talk about the exciting things happening in ag biotech and bioprocessing, we know this just means we have more time to plan an amazing BIO Impact Ag & Environment Conference for next year,” said Sylvia Wulf, chairman of the agriculture & environment section of the BIO board of directors and president & CEO of AquaBounty Technologies Inc. “We already had some great programming in the works for this year, so I know we’ll have an amazing agenda for 2023.”BIO, just weeks ago in mid-June, hosted the first in-person BIO International Convention in two years in San Diego, with more than 14,000 attendees from around the world and 44,000 BIO One-on-One Partnering™ meetings. In addition, BIO hosted a well-attended BIO Impact Ag & Environment Conference in 2019 in Iowa.“We are the no. 1 organization for companies, investors, researchers, and advocates in the biotechnology arena, and we have a proven track record of…
Read More

Good Day BIO: Congress passes drug price controls
Good Day BIO Newsletter  •  August 15, 2022
The House passed the Inflation Reduction Act on Friday, sending anti-science drug price controls to POTUS for signature. Meanwhile, inflation seems to be easing, but food prices are still high. Luckily, we have biotech to address some of the root causes. (548 words, 2 minutes, 44 seconds)
Read More